Expanded newborn screening update Prof Jim Bonham Clinical Director Sheffield Children’s NHS FT.

Slides:



Advertisements
Similar presentations
The Cochrane Library. What is The Cochrane Library? The Cochrane Library offers high-quality evidence for health care decision making
Advertisements

Tracking and Data Management Technical Assistance Workshop for Universal Newborn Hearing Screening and Intervention Margaret Lubke, Ph.D. National Center.
The EMPOWER Project - targeting children at risk of obesity Sue Hanson.
Copyright © Healthcare Quality Quest, Proposed standards for a national clinical audit — How we got involved and what we have learned.
NICE Guidance and Quality Standard on Patient Experience
Case Identification for the Missouri Perinatal Hepatitis B Prevention Program Libby Landrum, RN, MSN Viral Hepatitis Prevention Manager Bureau HIV, STD,
Children’s Heart Surgery Centres 1. Freeman’s Hospital 2. Leeds 3. Alder Hey Children's Hospital 4. University Hospitals Of Leicester NHS Trust 5. Birmingham.
Right First Time: Update. Overview Making sure Sheffield residents continue to get the best possible health services is the aim of a new partnership between.
An International Partnership for Rare Disorder Screening Dr Jim Bonham Clinical Director Sheffield Children’s NHS FT.
Perinatal Hepatitis B Prevention
CCG assurance & development
Prepared by Jane Hibbert on behalf of the Regional ANCH Screening Teams Expanded Newborn Screening Pilot 16th July 2012 – 19th July 2013 NIHR CLAHRC for.
August 2006 Newborn Screening Programmes. Introduction These slides bring you up to date with the three NSC Newborn Screening Programmes The Blood Spot.
Melissa Ewerth Graduate Adapted Physical Education, WCU.
Clear and Credible Plan Quarter 3 update Liane Langdon Director of Commissioning and Strategic Development Together we’re better.
AMCHP 2005 Conference The Expansion of the Tennessee Genetics and Newborn Screening Program and Website Teresa M. Blake, MS, Genetic Counselor Beth Wilson,
ISABEL: the Use of a Web-based Clinical Support System Dr Jim Briggs Dr Tineke Fitch University of Portsmouth, UK
Developmental Screening: What it Means for Early Learning Hubs November 21, 2013 Dana Hargunani, MD, MPH Child Health Director Oregon Health Authority.
Illinois Children’s Healthcare Foundation CHILDREN’S MENTAL HEALTH INITIATIVE Building Systems of Care: Community by Community Fostering Creativity Through.
© Copyright, The Joint Commission 2013 National Patient Safety Goals.
Epidemiology Tools and Methods Session 2, Part 1.
Development of Clinical Practice Guidelines for the NHS Dr Jacqueline Dutchak, Director National Collaborating Centre for Acute Care 16 January 2004.
Monitoring and evaluation: making your work count Dr Liz Weekes Consultant Dietitian & NIHR Clinical Lecturer Department of Nutrition & Dietetics Guy’s.
Your Child's Best Shot A parent's guide to vaccination.
VISION: Possibilities, Potentials and Progress Addressing unmet Regional Healthcare Access for Children.
Evidence Evaluation & Methods Workgroup: Developing a Decision Analysis Model Lisa A. Prosser, PhD, MS September 23, 2011.
Inspection of Safeguarding and Looked After Children 23 March 2012.
School Readiness: We’re Better Together
Yorkshire & Humber Information Skills Training Group Presentation to East Midlands Library Trainers’ Forum Tuesday 13 th July 2010.
Strategies for Readmission Reduction in Transitional Care: A Three (3) Part Process. Telehealth Alliance of Oregon Conference April 11 & 12, 2013 Jean.
Clinical Psychology and Cleft Care Dr Louise Dalton Consultant Clinical Psychologist, Spires Cleft Centre Chair, Cleft Psychology Special Interest Group.
Maria Roetto & Liz Hankins Utah State University LOCAL PHYSICIAN OUTREACH: NEWBORN HEARING EDUCATION AND RESOURCES.
S.A.F.E Situation Awareness For Everyone
2nd Concertation Meeting Brussels, September 8, 2011 Reinhard Prior, Scientific Coordinator, HIM Evidence in telemedicine: a literature review.
Pompe Disease Evidence Evaluation Michael Watson, PhD, on behalf of Piero Rinaldo, MD, PhD, and the Decision-Making Workgroup October 1, 2008.
Supporting people with active and advanced disease Need better data collection Discussion at MDT – new diagnosis support Identify best practice Early palliative.
Super User Forum 11 th July eWIN Super User Forum 11 th July 2011.
Devon Partnership NHS Trust Configuration Release 1 25/26 th May 2011 Briefing Session.
HOW ARE PRIORITY ISSUES FOR AUSTRALIA’S HEALTH IDENTIFIED? HEALTH PRIORITIES IN AUSTRALIA.
National Cancer Survivorship Initiative 2010 Update.
A DAY IN THE LIFE OF A HEALTH VISITOR. Jane Dingley (Health Visitor/Practice Teacher Oct 2013)
PREPARED BY The New Zealand Cancer Nurse Coordinator Initiative Natalie James National Nurse Lead May 2013.
Workshop 1 - Report IMPS IMproving Care in a Pregnancy after Stillbirth Central Manchester University Hospitals NHSFT University Hospital of South Manchester.
Care Quality Commission (CQC) Registration. Background The Care Quality Commission (CQC) is the health and social care regulator for England. From 1 April.
21st May  Demographic & Social  Aging population  Multiple long term conditions / skills development  Health & Social Care system design  Integration.
Public Health Nursing Competencies
Chapter 34 PRIMARY CARE Sian Maslin-Prothero, Sue Ashby and Sarah Taylor.
Outcomes – Gaye Powell. * “... a predicted measure of change that demonstrates a valid and significant therapeutic impact following an agreed intervention.”
Development of SafeT Kids Mobile App An injury prevention resource for parents Kerrie L. Roye Temple University.
IPP Infrastructure Measures of Effectiveness: Preliminary Data and Next Steps Kelly Morrison Opdyke, MPH Region II Infertility Prevention Project Cicatelli.
INFLUENCING PRESCRIBING BEHAVIOUR Dr Martin Duerden 1.
MCADD, caused by mutation in the ACADM gene is the most common disorder of fatty acid  - oxidation. Treatment is very successfully if started before symptoms.
Genes in Life is a place to learn about all the ways genetics is a part of your life. On this site you will learn:   How.
About Newborn Screening  Newborn Screening Facts - A brief introduction to the most important information on newborn screening.
Our five year plan to improve local health and care services.
Our five year plan to improve local health and care services
Antibiotics: handle with care!
Prevalence of Adverse Childhood Experiences
Danijela Radivojevic Laboratory of Medical Genetics
Reducing bias in randomised controlled trials involving therapists:
Stress Control in schools
Informing policy, Improving programs
The Centre for Community-Driven Research
Newborn screening Dr Jim Bonham Clinical Director
Severe Chronic Conditions Substantial Service Needs
The Ontario Experience National Immunization Conference
Data Collection Training, Part I Outcome Data
Daniel S. Shaw University of Pittsburgh
Professor Deborah Baker
Presentation transcript:

Expanded newborn screening update Prof Jim Bonham Clinical Director Sheffield Children’s NHS FT

Screening Results 1 st & 2 nd Quarter Number of expanded screening declines across the six sites: 193 (0.06%) Number of Expanded Screening Declines Number of Births Site1st Quarter Births2nd Quarter BirthsTotal Births Birmingham19,48518,48437,969 Great Ormond Street33,97032,06166,031 Guy's & St Thomas'16,59914,61731,216 Leeds12,07512,50524,580 Manchester15,54014,14129,681 Sheffield19,17819,44638,624 Total Births116,847111,254228,101 Estimated Births for 8 months = 304,134 Site 16/07 17/08 18/08 17/09 18/09 17/10 18/10 17/11 18/11 17/12 18/12 17/01 18/01 17/02 18/02 17/03 Site Totals Birmingham Great Ormond Street Guy's & St Thomas' Leeds Manchester Sheffield Total Declines

What were our expectations? ConditionPrevalence Screen positives True positives False positivesPPV% MSUD 1:116, HCys 1:144, GA1 1:109, IVA 1:155, LCHAD 1:218, TOTAL 1:28,

BirminghamMSUDHycsIVAGA1LCHADD TOTAL Expected by this time False positives True positives Sibling identified case GOSH False positives True positives Sibling identified case Guy ’ s & St Thomas ’ False positives True positives Sibling identified case Leeds False positives True positives Sibling identified case Manchester False positives True positives Sibling identified case Sheffield False positives True positives Sibling Identified case TotalMSUDHycsIVAGA1LCHADDTotal Expected False positives True positives PPV%4739 What have we found so far? (Jason Sowter)

Website Usage (Clare Gibson) The number of unique visitors per month has remained steady for the five months a rise was seen in February. There is a little fluctuation on the number of true visitors (defined as remaining at the website for more than 30 seconds) The majority of visitors spend less than 30 seconds at the site

Website Usage – Accessing translations Translated versions of the Parent & Health Professional leaflet have been accessed a total of 166 times in 8 different languages. Polish is the most commonly downloaded translation, followed by Turkish. Urdu is the only audio translation to be accessed (a total of 9 times)

Website Updates – The revised website

Website Updates The new website includes: Simplified information about each of the 5 conditions Access of all information for all (i.e. removal of the password restricted area) A suite of short films (produced in partnership with Optical Jukebox) describing the role of newborn screening and each of the five conditions Simplified access to important information – such as leaflet ordering and leaflet translations Front page links to other key websites (BIMDG and NSPC) An improved navigation structure including a search facility and bread crumbs The new website and the films were released at the Rare Diseases Day Parliamentary Reception at Houses of Parliament on 27th February 2013.

Website Usage - Queries 26 queries from NHS staff, 7 from members of public. Initial response times within 3 day time bracket. Most common query – ordering leaflets Midwives, health visitors & screening co-ordinators most common profession.

Issues to explore? Improving the assays Mild disease, particularly the IVA’s Evaluating the impact of false positive results Bridging work

Improving the assays EQA, Final Mackenzie Population data, Rodney Pollitt and Rachel Carling Circulation of samples with Int Std kit to identify analyser related variables, Rachel Carling

Mild disease, particularly the IVA’s  The issue  Two mild IVA’s in the first month  One of these includes the mild mutation  The other the child is well, consanguineous kindred, C5 at screening was 1.11 µmol/L (cut-off 1.00 µmol/L)  Urinary IVG modest  54.6 µmol/mmol cr  Infant control range : 0.06 – 1.20 (n=12)  Mild mutation : 23 – 79 (n=2)  Symptomatic patients : ,541 (n=9)  Treated conservatively on emergency regimen, older siblings being tested Further study  Do we need to look carefully at “mild case/ mutation experience” in similar populations eg UK/Netherlands/Germany and determine if we can stratify risk on a biochemical basis – metabolite or enzyme assay?

Evaluating the impact of false positives The problems  Parents tell us that false positives are not a huge problem in theory - Dixon S JIMD 2012  In practice the evidence is somewhat contradictory  Tu WJ PLoS One % of mothers with a false +ve result describe concerns about child’s future development vs 10% in the normal screened group  Waisbren SE et al JAMA 2003 Children with FP result twice as likely to experience hospitalisation 21% vs 10% and mothers report increased PSI score p<0.001 Vs  Lipstein EA Genet Med children with FP and 137 normal showed no difference in healthcare utilisation  Prosser LA Arch Pediatr Adol Med parents with FP result vs 50 with a normal. Demonstrated a high tolerance in a WTP study  Why is this and what do the parents want?  Many studies tell us that better communication reduces stress  Generally studies do not compare how the family was given the news or supported in the time to confirmation

Evaluating the impact of false positives A planned study, Dr Louise Moody  A detailed literature search  Identification of key issues that may confound studies  Determine the views of parents who have received a false positive screening result  Determine the views of parents who have received a true positive screening result  Determine the views of metabolic physicians, metabolic nurses and dietitians have delivered a result  Make reccomendations for best practice To begin in July 2013, complete in 2014

Bridging work Resources for patients  Videos  Podcast use  Written material  Website  Help line Resources for professionals  The diagnostic process and organisation of testing  Telemedicine support  Case definitions  Treatment protocols for a spectrum of disease

For the future Continuing the study after July 2013 Completing the CRF data collection and health economic evaluation (Prof Jim Chilcott, ScHARR) Presentation to the UKNSC Considering further conditions to be included and creating a northern European consensus – Literature search and meeting Continuing to develop the website - CLAHRC2 CAH – RFPB application